Marc Moesser

Lyceum is a GPU cloud platform built for AI teams in Europe. We offer inference APIs, serverless execution, GPU VMs, and managed clusters. Designed to work individually or together. Whether youre training and fine-tuning LLMs, running large-scale batch inference, powering real-time AI applications, or processing compute-heavy scientific workloads. Lyceum handles the infrastructure so you can focus on building.

Basecamp Research is an AI company dedicated to solving the most pressing challenges in the life sciences by exploring beyond known biology. The company discovers and designs proteins with artificial intelligence trained on its proprietary knowledge graph of nature, the largest and most diverse of its kind, to design biological solutions for pharma, food and industrial applications. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. Were a team of explorers, scientists and policy experts driven by our ambition to protect and learn from natures diversity, whilst delivering life-changing breakthroughs to those who need them most. – BCR

Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.

Creator Fund is a venture capital firm investing in startups on the frontier of whats possible. We back founders building deep technology businesses out of university innovation. We focus on PhD and academic founders and have teams on-the-ground across 28 university campuses. Our portfolio includes founders creating mutation-proof vaccines, electronic skin for robots, and allowing the human mind to control machines. We invest pre-seed and seed and work closely with our companies to scale and raise follow on rounds. CF has been backed by many leading funds in Europe and the US.

Lyceum is a GPU cloud platform built for AI teams in Europe. We offer inference APIs, serverless execution, GPU VMs, and managed clusters. Designed to work individually or together. Whether youre training and fine-tuning LLMs, running large-scale batch inference, powering real-time AI applications, or processing compute-heavy scientific workloads. Lyceum handles the infrastructure so you can focus on building.

Basecamp Research is an AI company dedicated to solving the most pressing challenges in the life sciences by exploring beyond known biology. The company discovers and designs proteins with artificial intelligence trained on its proprietary knowledge graph of nature, the largest and most diverse of its kind, to design biological solutions for pharma, food and industrial applications. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. Were a team of explorers, scientists and policy experts driven by our ambition to protect and learn from natures diversity, whilst delivering life-changing breakthroughs to those who need them most. – BCR

redalpine is the pan-European venture capital firm that empowers GameChangers. Founded in Switzerland in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management and a disciplined, sector-agnostic investment strategy, the firm has backed some of Europe’s most disruptive companies, including N26, Mistral AI, Proxima Fusion, Klarna, Taxfix, Inkitt, 9fin, and vivenu. redalpine has over 100 companies in its portfolio and invests Europe-wide from its offices in Zurich, Berlin, and London.

Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.

Creator Fund is a venture capital firm investing in startups on the frontier of whats possible. We back founders building deep technology businesses out of university innovation. We focus on PhD and academic founders and have teams on-the-ground across 28 university campuses. Our portfolio includes founders creating mutation-proof vaccines, electronic skin for robots, and allowing the human mind to control machines. We invest pre-seed and seed and work closely with our companies to scale and raise follow on rounds. CF has been backed by many leading funds in Europe and the US.